688293 奥浦迈
交易中 12-24 10:21:31
资讯
新帖
简况
奥浦迈收盘下跌1.78%,滚动市盈率118.06倍
金融界 · 12-23 20:23
奥浦迈收盘下跌1.78%,滚动市盈率118.06倍
奥浦迈收盘上涨0.45%,滚动市盈率120.19倍
金融界 · 12-20
奥浦迈收盘上涨0.45%,滚动市盈率120.19倍
奥浦迈12月18日遭主力抛售27万元 环比增加1250.00%
市场透视 · 12-18
奥浦迈12月18日遭主力抛售27万元 环比增加1250.00%
奥浦迈(688293.SH)主要股东华杰投资拟减持不超3%股份
智通财经 · 12-16
奥浦迈(688293.SH)主要股东华杰投资拟减持不超3%股份
奥浦迈股东华杰投资计划减持不超344万股
财中社 · 12-15
奥浦迈股东华杰投资计划减持不超344万股
奥浦迈最新公告:持股5%以上的股东华杰投资计划减持不超3%公司股份
证券之星 · 12-15
奥浦迈最新公告:持股5%以上的股东华杰投资计划减持不超3%公司股份
奥浦迈(688293)12月9日主力资金净卖出86.44万元
证券之星 · 12-10
奥浦迈(688293)12月9日主力资金净卖出86.44万元
奥浦迈12月05日主力资金流出78万元 连续7日减仓
市场透视 · 12-05
奥浦迈12月05日主力资金流出78万元 连续7日减仓
奥浦迈(688293)12月4日主力资金净卖出199.23万元
证券之星 · 12-05
奥浦迈(688293)12月4日主力资金净卖出199.23万元
12月4日奥浦迈跌5.59%,汇丰晋信龙腾混合A基金重仓该股
证券之星 · 12-04
12月4日奥浦迈跌5.59%,汇丰晋信龙腾混合A基金重仓该股
奥浦迈跌5.3% 6券商增持
智选洞察 · 12-04
奥浦迈跌5.3% 6券商增持
奥浦迈12月02日遭主力抛售389万元 环比增加135.76%
市场透视 · 12-02
奥浦迈12月02日遭主力抛售389万元 环比增加135.76%
奥浦迈11月29日主力资金流出165万元 连续3日减仓
市场透视 · 11-29
奥浦迈11月29日主力资金流出165万元 连续3日减仓
奥浦迈上涨5% 6券商增持
智选洞察 · 11-29
奥浦迈上涨5% 6券商增持
奥浦迈:11月26日召开业绩说明会,投资者参与
证券之星 · 11-27
奥浦迈:11月26日召开业绩说明会,投资者参与
奥浦迈:CDMO业务终端价格承压比较大的情况普遍存在
财经网 · 11-26
奥浦迈:CDMO业务终端价格承压比较大的情况普遍存在
【机构调研记录】鑫元基金调研天赐材料、奥浦迈
证券之星 · 11-26
【机构调研记录】鑫元基金调研天赐材料、奥浦迈
奥浦迈:东吴证券、华商基金等多家机构于11月21日调研我司
证券之星 · 11-25
奥浦迈:东吴证券、华商基金等多家机构于11月21日调研我司
奥浦迈股价涨5% 回购股份注销
智选洞察 · 11-20
奥浦迈股价涨5% 回购股份注销
奥浦迈:11月14日接受机构调研,淡水泉(北京)投资管理有限公司、东方证券(自营)等多家机构参与
证券之星 · 11-19
奥浦迈:11月14日接受机构调研,淡水泉(北京)投资管理有限公司、东方证券(自营)等多家机构参与
公司概况
公司名称:
上海奥浦迈生物科技股份有限公司
所属行业:
研究和试验发展
上市日期:
2022-09-02
主营业务:
上海奥浦迈生物科技股份有限公司是一家专门从事细胞培养产品与服务的高新技术企业。公司以细胞培养技术和工艺开发为基础,主营业务涉及细胞培养基系列产品和生物药委托开发生产服务两大应用领域。公司的主要产品有目培养基业务、CDMO业务、CHO培养基、293培养基。公司及其子公司已获得5项发明专利,62项实用新型专利和2项外观专利。公司获得“高新技术企业”、上海市“专精特新”、上海市科技小巨人培育企业等称号。
发行价格:
80.20
{"stockData":{"symbol":"688293","market":"SH","secType":"STK","nameCN":"奥浦迈","latestPrice":39.68,"timestamp":1735006891000,"preClose":39.18,"halted":0,"volume":99959,"delay":0,"floatShares":78633000,"shares":114999999,"eps":0.3319,"marketStatus":"交易中","marketStatusCode":2,"change":0.5,"latestTime":"12-24 10:21:31","open":39.09,"high":40.15,"low":39.08,"amount":3986000,"amplitude":0.0273,"askPrice":39.8,"askSize":6,"bidPrice":39.68,"bidSize":8,"shortable":0,"etf":0,"ttmEps":0.3319,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1735011000000},"adr":0,"adjPreClose":39.18,"symbolType":"stock_kcb","openAndCloseTimeList":[[1735003800000,1735011000000],[1735016400000,1735023600000]],"highLimit":43.1,"lowLimit":35.26,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":114772460,"pbRate":2.14,"roa":"--","roe":"1.26%","epsLYR":0.47,"committee":0.408451,"marketValue":4554000000,"floatMarketCap":3120000000,"peRate":119.554082,"changeRate":0.0128,"turnoverRate":0.0013,"status":0},"requestUrl":"/m/hq/s/688293/wiki","defaultTab":"wiki","newsList":[{"id":"2493754661","title":"奥浦迈收盘下跌1.78%,滚动市盈率118.06倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2493754661","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493754661?lang=zh_cn&edition=full","pubTime":"2024-12-23 20:23","pubTimestamp":1734956627,"startTime":"0","endTime":"0","summary":"12月23日,奥浦迈今日收盘39.18元,下跌1.78%,滚动市盈率PE达到118.06倍。从行业市盈率排名来看,公司所处的专业服务行业市盈率平均56.13倍,行业中值29.43倍,奥浦迈排名第30位。截至2024年三季报,共有14家机构持仓奥浦迈,其中基金10家、其他4家,合计持股数4718.57万股,持股市值15.90亿元。上海奥浦迈生物科技股份有限公司是一家专门从事细胞培养产品与服务的高新技术企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223202719ab8e0167&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223202719ab8e0167&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2492448594","title":"奥浦迈收盘上涨0.45%,滚动市盈率120.19倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2492448594","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492448594?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:53","pubTimestamp":1734699239,"startTime":"0","endTime":"0","summary":"12月20日,奥浦迈今日收盘39.89元,上涨0.45%,滚动市盈率PE达到120.19倍。从行业市盈率排名来看,公司所处的专业服务行业市盈率平均57.80倍,行业中值30.75倍,奥浦迈排名第30位。截至2024年三季报,共有14家机构持仓奥浦迈,其中基金10家、其他4家,合计持股数4718.57万股,持股市值15.90亿元。上海奥浦迈生物科技股份有限公司是一家专门从事细胞培养产品与服务的高新技术企业。公司及其子公司已获得5项发明专利,62项实用新型专利和2项外观专利。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220205802ab8728c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220205802ab8728c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2492082649","title":"奥浦迈12月18日遭主力抛售27万元 环比增加1250.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492082649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492082649?lang=zh_cn&edition=full","pubTime":"2024-12-18 15:20","pubTimestamp":1734506428,"startTime":"0","endTime":"0","summary":"12月18日, 奥浦迈股价跌0.30%,报收39.92元,成交金额970万元,换手率0.31%,振幅3.17%,量比0.64。奥浦迈今日主力资金净流出27万元,连续3日净流出,上一交易日主力净流出2万元,今日环比增加1250.00%。该股近5个交易日下跌9.02%,主力资金累计净流出450万元;近20日主力资金累计净流出2271万元,其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218154626a1f7ec63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218154626a1f7ec63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2491049745","title":"奥浦迈(688293.SH)主要股东华杰投资拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2491049745","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491049745?lang=zh_cn&edition=full","pubTime":"2024-12-16 06:55","pubTimestamp":1734303306,"startTime":"0","endTime":"0","summary":"智通财经APP讯,奥浦迈(688293.SH)公告,公司持股5%以上股东宁波梅山保税港区铧杰股权投资管理有限公司-华杰(天津)医疗投资合伙企业(有限合伙)(简称“华杰投资”)计划自2025年1月7日起至2025年4月6日期间,通过大宗交易和集中竞价交易的方式合计减持公司股份不超过344.32万股,合计减持比例占公司目前总股本的比例不超过3.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225096.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2491527671","title":"奥浦迈股东华杰投资计划减持不超344万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491527671","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491527671?lang=zh_cn&edition=full","pubTime":"2024-12-15 20:05","pubTimestamp":1734264300,"startTime":"0","endTime":"0","summary":"奥浦迈(688293)发布持股5%以上的股东减持股份计划公告。根据公告,华杰投资目前持有公司股份993万股,占总股本的8.65%。华杰投资因自身资金需求,计划自2025年1月7日起至2025年4月6日期间,通过大宗交易和集中竞价交易的方式合计减持不超过344万股,减持比例不超过3%。公告中提到,华杰投资在过去12个月内已减持134万股,占其持股比例的1.16%。此次减持计划的实施时间和数量将根据市场情况进行调整,存在不确定性。华杰投资承诺将严格遵守相关法律法规,并在减持前进行信息披露。2024年前三季度,奥浦迈实现收入2.16亿元,归母净利润2723万元。(文章来源:财中社)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241215201202ab79c049&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241215201202ab79c049&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2491524680","title":"奥浦迈最新公告:持股5%以上的股东华杰投资计划减持不超3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2491524680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491524680?lang=zh_cn&edition=full","pubTime":"2024-12-15 18:49","pubTimestamp":1734259790,"startTime":"0","endTime":"0","summary":"奥浦迈公告称,公司持股5%以上的股东华杰投资计划自2025年1月7日起至2025年4月6日期间,通过大宗交易和集中竞价交易的方式合计减持公司股份不超过3,443,173股,合计减持比例占公司目前总股本的比例不超过3.00%。华杰投资目前持有公司股份9,929,542股,持股比例8.65%。本次减持计划系股东华杰投资根据自身资金需求进行的减持,减持的数量、时间和价格存在不确定性。华杰投资本次减持计划将严格遵守相关法律法规的规定,并及时履行信息披露义务。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121500002263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2490038070","title":"奥浦迈(688293)12月9日主力资金净卖出86.44万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490038070","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490038070?lang=zh_cn&edition=full","pubTime":"2024-12-10 08:27","pubTimestamp":1733790470,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年12月9日收盘,奥浦迈报收于44.59元,下跌2.47%,换手率0.39%,成交量3063.0手,成交额1392.3万元。近5日资金流向一览见下表:奥浦迈融资融券信息显示,融资方面,当日融资买入188.54万元,融资偿还153.21万元,融资净买入35.32万元。奥浦迈主营业务:从事细胞培养产品与服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121000009166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2489461225","title":"奥浦迈12月05日主力资金流出78万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2489461225","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489461225?lang=zh_cn&edition=full","pubTime":"2024-12-05 15:21","pubTimestamp":1733383270,"startTime":"0","endTime":"0","summary":"12月05日, 奥浦迈股价涨0.09%,报收45.31元,成交金额1120万元,换手率0.32%,振幅2.83%,量比0.31。奥浦迈今日主力资金净流出78万元,连续7日净流出,上一交易日主力净流出187万元,今日环比减少58.29%。该股近5个交易日上涨2.98%,主力资金累计净流出1038万元;近20日主力资金累计净流入2251万元,其中净流入天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205153951ab5f1e9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205153951ab5f1e9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2489783911","title":"奥浦迈(688293)12月4日主力资金净卖出199.23万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489783911","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489783911?lang=zh_cn&edition=full","pubTime":"2024-12-05 08:21","pubTimestamp":1733358071,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年12月4日收盘,奥浦迈报收于45.27元,下跌5.59%,换手率0.79%,成交量6190.0手,成交额2895.4万元。近5日资金流向一览见下表:奥浦迈融资融券信息显示,融资方面,当日融资买入284.69万元,融资偿还228.45万元,融资净买入56.25万元,连续3日净买入累计1130.06万元。奥浦迈主营业务:从事细胞培养产品与服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120500007037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2488564821","title":"12月4日奥浦迈跌5.59%,汇丰晋信龙腾混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488564821","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488564821?lang=zh_cn&edition=full","pubTime":"2024-12-04 16:08","pubTimestamp":1733299717,"startTime":"0","endTime":"0","summary":"证券之星消息,12月4日奥浦迈跌5.59%创60日新高,收盘报45.27元,换手率0.79%,成交量6190.0手,成交额2895.4万元。根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共8家,其中持有数量最多的公募基金为汇丰晋信龙腾混合A。汇丰晋信龙腾混合A目前规模为9.1亿元,最新净值1.3081,较上一交易日上涨0.4%,近一年上涨10.3%。汇丰晋信龙腾混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120400027501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2488534251","title":"奥浦迈跌5.3% 6券商增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2488534251","media":"智选洞察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488534251?lang=zh_cn&edition=full","pubTime":"2024-12-04 14:27","pubTimestamp":1733293658,"startTime":"0","endTime":"0","summary":"12月04日,奥浦迈股价大幅下跌,截至14点27分,奥浦迈下跌5.30%,报45.41元/股,成交1966万元,换手率0.53%。融资融券方面,奥浦迈12月02日获得融资净买入1072万元,当日该股融资余额为2.58亿元,当较前一日增加4.34%,实现2连增。主营业务及业绩奥浦迈公司主营业务为从事细胞培养产品与服务。最新财报显示,今年三季报,奥浦迈实现营业收入2.16亿元,同比增长25.73%,净利润为2,723.48万元,同比减少36.93%,基本每股收益为0.24元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204142745a26b5e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204142745a26b5e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2488962821","title":"奥浦迈12月02日遭主力抛售389万元 环比增加135.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488962821","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488962821?lang=zh_cn&edition=full","pubTime":"2024-12-02 15:19","pubTimestamp":1733123992,"startTime":"0","endTime":"0","summary":"12月02日, 奥浦迈股价涨3.94%,报收47.98元,成交金额5553万元,换手率1.50%,振幅6.72%,量比1.70。奥浦迈今日主力资金净流出389万元,连续4日净流出,上一交易日主力净流出165万元,今日环比增加135.76%。该股近5个交易日上涨11.63%,主力资金累计净流出730万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1902万元,其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202153339abef06dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202153339abef06dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2487589287","title":"奥浦迈11月29日主力资金流出165万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2487589287","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487589287?lang=zh_cn&edition=full","pubTime":"2024-11-29 15:19","pubTimestamp":1732864758,"startTime":"0","endTime":"0","summary":"11月29日, 奥浦迈股价涨4.91%,报收46.16元,成交金额3826万元,换手率1.06%,振幅8.02%,量比1.32。奥浦迈今日主力资金净流出165万元,连续3日净流出,上一交易日主力净流出97万元,今日环比增加70.10%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为46.67%,平均跌幅为3.40%。该股近5个交易日上涨7.90%,主力资金累计净流出1030万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入2469万元,其中净流入天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129152858abe7f648&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129152858abe7f648&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2487588187","title":"奥浦迈上涨5% 6券商增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2487588187","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487588187?lang=zh_cn&edition=full","pubTime":"2024-11-29 14:31","pubTimestamp":1732861868,"startTime":"0","endTime":"0","summary":"11月29日,奥浦迈股价大幅上涨,截至14点31分,奥浦迈上涨5.25%,报46.31元/股,成交2843万元,换手率0.80%,振幅6.73%。资金动向截止发稿,奥浦迈获得主力净流出161万元,其中超大单流入113万元,大单流出273万元。主营业务及业绩奥浦迈公司主营业务为从事细胞培养产品与服务。最新财报显示,今年三季报,奥浦迈实现营业收入2.16亿元,同比增长25.73%,净利润为2,723.48万元,同比减少36.93%,基本每股收益为0.24元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129143119abe7d664&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129143119abe7d664&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2486864868","title":"奥浦迈:11月26日召开业绩说明会,投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2486864868","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486864868?lang=zh_cn&edition=full","pubTime":"2024-11-27 10:32","pubTimestamp":1732674775,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年11月26日奥浦迈发布公告称公司于2024年11月26日召开业绩说明会。非常感谢您对奥浦迈的关注,谢谢。上述项目建设完成后,公司CDMO业务已经拥有承接临床三期及后期商业化服务的能力,服务范围已补充完整。奥浦迈主营业务:从事细胞培养产品与服务。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700012608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2486016240","title":"奥浦迈:CDMO业务终端价格承压比较大的情况普遍存在","url":"https://stock-news.laohu8.com/highlight/detail?id=2486016240","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486016240?lang=zh_cn&edition=full","pubTime":"2024-11-26 11:41","pubTimestamp":1732592512,"startTime":"0","endTime":"0","summary":"公司2024年第三季度CDMO业务相较于去年同期相比呈现出正向增加,当然也和去年同期的基数相对较小有关。目前来看,在现行市场环境下,CDMO业务终端价格承压比较大是普遍存在的情况。我们相信,未来行业出清之后,伴随着客户项目的持续正常推进,CDMO业务的亏损将进一步缩小。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126114213a255febd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126114213a255febd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2486098452","title":"【机构调研记录】鑫元基金调研天赐材料、奥浦迈","url":"https://stock-news.laohu8.com/highlight/detail?id=2486098452","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486098452?lang=zh_cn&edition=full","pubTime":"2024-11-26 08:02","pubTimestamp":1732579370,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及11月25日披露的机构调研信息,鑫元基金近期对2家上市公司进行了调研,相关名单如下:1)天赐材料 个股亮点:公司目前有LiFSI产能2300吨,21年Q4新投产4000吨后产能达到6300吨,22年底达到1.2万吨,远期规划总产能6万吨。旗下最近一年表现最佳的公募基金产品为鑫元数字经济混合发起式A,最新单位净值为1.17,近一年增长20.24%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112600007551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002709","BK0028","BK0077","LU0543330566.HKD","688293","LU0320764243.SGD","BK0155","BK0216","LU0229945570.USD","BK0229","LU0708995153.HKD","LU0128522744.USD","LU0029874905.USD"],"gpt_icon":0},{"id":"2486084378","title":"奥浦迈:东吴证券、华商基金等多家机构于11月21日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2486084378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486084378?lang=zh_cn&edition=full","pubTime":"2024-11-25 21:33","pubTimestamp":1732541608,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年11月25日奥浦迈发布公告称东吴证券张坤、华商基金孙蔚 胡世超于2024年11月21日调研我司。答:公司2024年第三季度CDMO业务相较于去年同期相比呈现出正向增加,当然也和去年同期的基数相对较小有关。目前来看,在现行市场环境下,CDMO业务终端价格承压比较大是普遍存在的情况。如有相关进展,公司会协助股东及时履行信息披露义务,请关注相关公告。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112500031539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0012","BK0183","BK0009","688293","BK0028","601555","BK0276","BK0216"],"gpt_icon":0},{"id":"2484213384","title":"奥浦迈股价涨5% 回购股份注销","url":"https://stock-news.laohu8.com/highlight/detail?id=2484213384","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484213384?lang=zh_cn&edition=full","pubTime":"2024-11-20 10:11","pubTimestamp":1732068671,"startTime":"0","endTime":"0","summary":"11月20日,奥浦迈股价大幅上涨,截至10点11分,奥浦迈上涨5.01%,报45.09元/股,成交953万元,换手率0.28%,振幅6.45%。主营业务及业绩奥浦迈公司主营业务为从事细胞培养产品与服务。最新财报显示,今年三季报,奥浦迈实现营业收入2.16亿元,同比增长25.73%,净利润为2,723.48万元,同比减少36.93%,基本每股收益为0.24元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120101132a2473c8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120101132a2473c8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2484958403","title":"奥浦迈:11月14日接受机构调研,淡水泉(北京)投资管理有限公司、东方证券(自营)等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2484958403","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484958403?lang=zh_cn&edition=full","pubTime":"2024-11-19 09:33","pubTimestamp":1731980027,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年11月18日奥浦迈发布公告称公司于2024年11月14日接受机构调研,淡水泉(北京)投资管理有限公司、东方证券(自营)、长信基金管理有限责任公司、东吴基金管理有限公司、大成基金管理有限公司、招商基金管理有限公司、汇添富基金管理股份有限公司、银华基金管理股份有限公司、嘉实基金管理有限公司、华富基金管理有限公司、国泰基金管理有限公司、天风(上海)证券资产管理有限公司参与。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111900008816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0276","03958","688293","BK1564","BK1147","BK0216","600958","BK0183","BK0028","BK0012"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-09-02","address":"上海市浦东新区紫萍路908弄28号","stockEarnings":[{"period":"1week","weight":-0.0397},{"period":"1month","weight":-0.0842},{"period":"3month","weight":0.5198},{"period":"6month","weight":0.1822},{"period":"1year","weight":-0.2523},{"period":"ytd","weight":-0.2796}],"companyName":"上海奥浦迈生物科技股份有限公司","boardCode":"AI0073","perCapita":"24696股","boardName":"研究和试验发展","registeredCapital":"11477万元","compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.1705},{"period":"6month","weight":0.1274},{"period":"1year","weight":0.1497},{"period":"ytd","weight":0.1265}],"survey":" 上海奥浦迈生物科技股份有限公司是一家专门从事细胞培养产品与服务的高新技术企业。公司以细胞培养技术和工艺开发为基础,主营业务涉及细胞培养基系列产品和生物药委托开发生产服务两大应用领域。公司的主要产品有目培养基业务、CDMO业务、CHO培养基、293培养基。公司及其子公司已获得5项发明专利,62项实用新型专利和2项外观专利。公司获得“高新技术企业”、上海市“专精特新”、上海市科技小巨人培育企业等称号。","serverTime":1735006988565,"listedPrice":80.2,"stockholders":"3184人(较上一季度减少2.78%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥浦迈(688293)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥浦迈(688293)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥浦迈,688293,奥浦迈股票,奥浦迈股票老虎,奥浦迈股票老虎国际,奥浦迈行情,奥浦迈股票行情,奥浦迈股价,奥浦迈股市,奥浦迈股票价格,奥浦迈股票交易,奥浦迈股票购买,奥浦迈股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥浦迈(688293)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥浦迈(688293)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}